LVTX Lava Tx: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik LAVA Therapeutics NV (LVTX)

The secure operations of LAVA Therapeutics N.V. (LVTX) within the EU and US frameworks minimize external threats. The company's price-to-sales multiple demonstrates this stability, with the -781.56 metric serving as the target level. Growth is based on the independence of clinical trials from GDP, although the lack of revenue and risks regarding antibody efficacy exert significant pressure on the capitalization.

Nilai perusahaan marang pendapatan: Lava Tx (LVTX) kanggo 23.11.2025 - 06.12.2025

Lava Tx - rincian analitis lan metrik utama (LVTX)

- rega saham lan konsensus proyeksi valuasi:
- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:LAVA Therapeutics NV LVTX
Sampel barang LAVA Therapeutics NV

This indicator measures the market value of the business, including net debt, relative to generated sales volume, allowing for an assessment of the premium for future revenue growth. By analyzing the Enterprise Value to revenue ratio for LAVA Therapeutics N.V. (LVTX), an investor can discern the value of immuno-oncology innovations, which remains stable regardless of macroeconomic cycles and inflationary fluctuations, determining the long-term capitalization potential.

Analisis pesaing LAVA Therapeutics N.V.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP